AgranulocytosisNeutropeniaFebrile NeutropeniaChemotherapy-Induced Febrile NeutropeniaAntithyroid AgentsMethimazoleLevamisoleClozapineDrug ContaminationGranulocyte Colony-Stimulating FactorPropylthiouracilTaxoidsVeterinary DrugsDrug Administration SchedulePhenylbutazoneLeukopeniaDibenzazepinesChlorpropamideGraves DiseaseHLA-B38 AntigenAntinematodal AgentsPaclitaxelAcecainideDipyroneTreatment OutcomeGlutethimideDrug-Related Side Effects and Adverse ReactionsNeoplasmsInfusions, IntravenousAnemia, AplasticLeukocyte CountHypochlorous AcidMeprobamateMaximum Tolerated DoseDeoxycytidineFever of Unknown OriginCamptothecinCisplatinAntineoplastic Agents, PhytogenicMycosesPancytopeniaBone MarrowAntineoplastic AgentsUnited States Public Health ServiceVinblastineFluorouracilHematologic NeoplasmsEpirubicinChlorpromazineDoxorubicinBone Marrow ExaminationNeutrophilsThrombocytopeniaHematologic DiseasesPyridonesCyclophosphamideAmodiaquineSurvival AnalysisNew MexicoAntipsychotic AgentsBacterial InfectionsCarboplatinDisease-Free SurvivalLung NeoplasmsRetrospective StudiesDose-Response Relationship, DrugAnti-Bacterial AgentsOrganoplatinum CompoundsHyperthyroidismOpportunistic InfectionsAntibiotic ProphylaxisIfosfamidePeroxidasePenicillanic AcidSurvival RateLeucovorinDrug MonitoringImmunocompromised HostBreast NeoplasmsNeoplasm MetastasisNauseaMucositisCarcinoma, Non-Small-Cell LungEtoposideProspective StudiesAnthracyclinesBacteremiaNeoplasm Staging